Mazdutide 10mg Vial Bali | Atlas Longevity
Rp1,500,000.00 ~$90.91
Discover Mazdutide 10mg, a dual GLP-1 and glucagon receptor agonist investigated in clinical research involving obesity, appetite regulation and metabolic health.
Mazdutide differs from conventional GLP-1 receptor agonists because it also activates the glucagon receptor.
- Mazdutide – 10mg per vial
- Dual GLP-1 and glucagon receptor agonist
- Investigated for weight management and metabolic health
- Clinical research involving obesity and glucose regulation
- Premium Atlas Longevity presentation
- Batch-specific testing documentation available on request, where applicable
Important: Mazdutide’s regulatory status varies by country. This listing does not establish approval for human use or sale in Indonesia.
Use code WELCOME20 at checkout. Orders over Rp3,000,000.
Use code ATLAS30 at checkout. Orders over Rp5,000,000.
Available on backorder
- COA Verified
- Same-Day Dispatch
- Ships from Bali
- SSL Secure
Mazdutide 10mg Bali – Dual GLP-1/Glucagon Peptide
What Is Mazdutide?
Mazdutide is a peptide-based dual receptor agonist that targets both glucagon-like peptide-1 (GLP-1) and glucagon receptors.
It has been investigated in clinical studies involving obesity, body weight, appetite regulation and metabolic outcomes.
Unlike single-receptor GLP-1 medicines, mazdutide combines GLP-1 receptor activity with glucagon receptor activation.
How Does Mazdutide Work?
Mazdutide acts on two hormonal pathways:
GLP-1 Receptor
GLP-1 receptor activation is associated with appetite regulation, glucose-dependent insulin secretion and gastrointestinal effects.
Glucagon Receptor
Glucagon receptor activation influences hepatic glucose metabolism and energy-related biological pathways.
The combination is being studied for its effects on body weight and metabolic regulation.
Mazdutide Research Areas
Clinical research has investigated mazdutide in relation to:
- Body-weight reduction
- Appetite and food-intake regulation
- Obesity management
- Blood glucose regulation
- Cardiometabolic risk factors
- Liver-related metabolic measurements
- Dual incretin and glucagon receptor signalling
Research findings depend on the population, study design, formulation and dose investigated. They do not establish the safety or efficacy of an independently supplied vial.
Mazdutide vs Semaglutide vs Tirzepatide vs Retatrutide
| Compound | Main Receptor Targets |
|---|---|
| Mazdutide | GLP-1 + Glucagon |
| Semaglutide | GLP-1 |
| Tirzepatide | GLP-1 + GIP |
| Retatrutide | GLP-1 + GIP + Glucagon |
These compounds have different clinical evidence, regulatory statuses and safety profiles. They are not interchangeable.
Mazdutide 10mg Product Specifications
Product: Mazdutide
Strength: 10mg
Brand: Atlas Longevity
Format: Peptide vial
Compound Class: Dual GLP-1/Glucagon Receptor Agonist
Research Area: Metabolic Health and Obesity
Quantity: 1 vial
Formulation and Excipients: Confirm against batch documentation
Quality & Batch Documentation
Atlas Longevity provides information on available batch-specific testing documentation.
Relevant documents may include compound identity, purity and other applicable analytical results.
A Certificate of Analysis does not, by itself, establish sterility, pharmaceutical approval or suitability for injection.
Storage
Follow the verified storage instructions for the specific formulation and batch.
Avoid excessive heat, direct sunlight and contamination.
Do not assume stability or storage duration after reconstitution without formulation-specific evidence.
Potential Side Effects
Clinical studies of mazdutide have reported gastrointestinal adverse events, including:
- Nausea
- Vomiting
- Diarrhoea
- Reduced appetite
- Other gastrointestinal discomfort
Additional risks and contraindications depend on the authorised product and clinical setting.
Atlas Longevity
Atlas Longevity provides information about peptide compounds and metabolic health research.
For enquiries about product documentation, formulation and regulatory status, contact our support team.
Frequently Asked Questions
What is Mazdutide?
Mazdutide is a dual GLP-1 and glucagon receptor agonist investigated for obesity and metabolic conditions.
What strength is this Mazdutide vial?
The vial is labelled as containing 10mg of mazdutide.
How does Mazdutide work?
Mazdutide activates GLP-1 and glucagon receptors, which are involved in appetite, glucose regulation and metabolic signalling.
Is Mazdutide the same as Semaglutide?
No. Semaglutide targets the GLP-1 receptor, while mazdutide targets both GLP-1 and glucagon receptors.
Is Mazdutide the same as Tirzepatide?
No. Tirzepatide activates GLP-1 and GIP receptors. Mazdutide activates GLP-1 and glucagon receptors.
What is the difference between Mazdutide and Retatrutide?
Mazdutide targets GLP-1 and glucagon receptors. Retatrutide targets GLP-1, GIP and glucagon receptors.
Is Mazdutide being studied for weight loss?
Yes. Mazdutide has been investigated in clinical trials involving obesity and weight reduction.
Does Mazdutide affect appetite?
GLP-1 receptor activity is associated with appetite regulation, and appetite-related outcomes have been investigated in mazdutide research.
Is Mazdutide approved in Indonesia?
Approval and legal supply status must be verified with the Indonesian regulatory authorities. Approval in another country does not establish approval in Indonesia.
Is Mazdutide 10mg suitable for injection?
A vial’s labelled strength or purity testing alone cannot establish that it is a sterile, approved injectable medicine.
Is a Certificate of Analysis available?
Contact Atlas Longevity to request available batch-specific analytical documentation.
Disclaimer
Mazdutide is a pharmacologically active peptide. Its approval, prescribing requirements and permitted uses depend on the jurisdiction.
This content is educational and does not provide medical dosing or administration instructions. Do not use an unapproved or unverified formulation for self-treatment.

Peptide Vials
Peptide Pens
Peptide Nasal Sprays
Peptide Protocols
Bundles